Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peppermint aromatherapy for prevention of intrathecal morphine-induced nausea and vomiting
NCT03434340Completed
- Sponsor
- Hospital Canselor Tuanku Muhriz
- Start
- Jun 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of peppermint oil in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Hospital Canselor Tuanku Muhriz. Primary endpoint: Severity of nausea and vomiting at 24 hours. Started Jun 2018; status: completed.
02
Drugs
peppermint oil
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT03434340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03434340.